type 1 diabetes
Item
type 1 diabetes for at least 12 months
boolean
C0011854 (UMLS CUI [1])
soluble human insulin, lispro, nph insulin, lantus
Item
currently on basal bolus treatment with soluble human insulin, lispro and nph insulin or lantus. nph insulin may be administered once or twice daily
boolean
C0795635 (UMLS CUI [1])
C0293359 (UMLS CUI [2])
C0021658 (UMLS CUI [3])
C0907402 (UMLS CUI [4])
bmi
Item
bmi (body mass index) maximum 35 kg/m^2
boolean
C1305855 (UMLS CUI [1])
self blood glucose monitoring
Item
able and willing to perform self-blood glucose monitoring
boolean
C0005803 (UMLS CUI [1])
investigational drug
Item
the receipt of any investigational drug within the last 30 days prior to this trial
boolean
C0013230 (UMLS CUI [1])
total daily insulin dose
Item
total daily insulin dose at least 1.8 u/kg/day
boolean
C2348070 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
insulin aspart
Item
currently being treated with insulin aspart products
boolean
C1708521 (UMLS CUI [1])
substance abuse
Item
a history of drug abuse or alcohol dependence within the last 5 years
boolean
C0038586 (UMLS CUI [1])
impaired hepatic function
Item
impaired hepatic function
boolean
C0232741 (UMLS CUI [1])
renal function
Item
impaired renal function
boolean
C0232804 (UMLS CUI [1])
blood donation, hemoglobin
Item
blood donation (exceeding 500 ml) within the last nine weeks or haemoglobin below the lower reference limit according to the local laboratory
boolean
C0005794 (UMLS CUI [1])
C0019046 (UMLS CUI [2])
cardiac problems
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
hypertension
Item
severe, uncontrolled hypertension
boolean
C0020538 (UMLS CUI [1])